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Many polyphenolic compounds have demonstrated anticarcinogenic activities in animal models.
These compounds include flavanone, flavonols, isoflavone, and catechins. In this article, tea
catechins will be used as an example to illustrate current research in this area. Many laboratory
studies have demonstrated the inhibition of tumorigenesis in animal models by different tea
preparations. The animal models include tumorigenesis in the mouse lung, rat and mouse
esophagi, mouse forestomach, mouse skin, mouse duodenum, rat small intestine, rat and mouse
livers, and rat colon. In most of the studies, the inhibitory activity of tea could be demonstrated
when tea preparations were given either during or after the carcinogen treatment period. Black
tea was also effective, although the activity was weaker than green tea in some experiments.
Decaffeinated tea preparations were also active in many model systems. The molecular
mechanisms for these broad inhibitory actions are not fully understood. They are most likely
related to the biochemical actions of the tea polyphenols, which include antioxidative activities
and inhibition of cell proliferation and of tumor promotion-related activities. The effect of tea
consumption on human cancers is not clear in spite of numerous investigations. The bioavailability
and pharmacokinetics of tea polyphenols are being studied in animals and humans to provide a
basis for more quantitative analyses on the effect of tea on carcinogenesis. More mechanistic
and dose-response studies will help us to understand the effects of tea consumption on human
carcinogenesis. Environ Health Perspect 105(Suppl 4):971-976 (1997)
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Introduction
Frequent consumption offruits and vegeta-
bles has been associated with lower inci-
dence ofcancers at different organ sites (1).
Several factors may contribute to this asso-
ciation. First, the nutrients in fruits and
vegetables, notably vitamin C, vitamin E,
folic acid, provitamin A, selenium, and
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zinc, are essential for normal cellular func-
tions. A deficiency in these nutrients may
enhance the susceptibility ofan individual
to cancer. Second, some nutrients, such as
vitamin C, vitamin E, selenium, and
n-carotene, at levels above nutritional
needs, may display inhibitory activities
against carcinogenesis. A third factor is that
nonnutritive constituents, such as polyphe-
nols, organosulfur compounds, and indoles,
have anticarcinogenic activities. Finally,
fruits and vegetables contribute fiber and
bulkiness to the diet. Persons who consume
large amounts offruits and vegetables may
eat smaller amounts ofmeat and other ani-
mal products that may contribute to higher
cancer incidences in theWestern countries.
The involvement ofthe first two factors
is supported bythe demonstration that sup-
plementation ofa high cancer risk popula-
tion in Linxian, China, with tablets
containing a-tocopherol, P-carotene, and
selenium for 63 months significantly low-
ered the mortality rate ofgastric (mainly
gastric cardia) cancer (2). The subjects
involved in this intervention study were
known to have low micronutrient status
(3,4). Supplementation with these antiox-
idant nutrients apparently produced a
protective effect against this cancer. It is
not known how much of the beneficial
effect is due to the antioxidant functions
of these intervention agents. Many plant
polyphenolic compounds also possess
antioxidative as well as other biological
activities. The anticancer activities of
some ofthese compounds have been stud-
ied by many investigators. This report dis-
cusses the possible anticancer activities of
the plant polyphenolic compounds that
are widely distributed in our food and
beverages. The activities offlavonoids will
be discussed in general. Studies on tea
polyphenols will be discussed in detail to
illustrate the opportunities and difficulties
in this area ofresearch.
Effects of Flavonoids
on Carcinogen Metabolism
and Carcinogenesis
Flavonoids and their glycosides are widely
distributed in fruits, vegetables, and nuts.
Naturally occurring flavonoids such as
flavonols, flavanones, isoflavones, and cate-
chins are structurally related to the parent
compound, flavone (2-phenylbenzopyrone)
(5). It has been estimated that humans
consume approximately 1 g of mixed
flavonoids per day (5).
Flavones such as tangeretin and
nobiletin, which occur in citrus fruits, affect
carcinogen metabolism, including the
enhancement ofmetabolism in vivo and
either the inhibition or stimulation of
metabolism in vitro (6). The action in vitro
appeared to depend on the cytochrome
P450 enzymes involved. For example,
P4501A2-dependent reactions are inhib-
ited, but P4503A4-dependent reactions are
enhanced, by tangeretin (7). The effects of
these compounds on carcinogen activation
in vivo and on carcinogenesis, however,
remain to be investigated.
Flavonols, such as quercetin and its gly-
coside, rutin, are prevalent in fruits, vegeta-
bles, and cereal grains. Rutin is hydrolyzed
by intestinal bacteria to quercetin in
humans. Quercetin is a potent inhibitor of
P450 reactions including the activation of
aflatoxin B1 by P4503A4 and the activation
ofbenzo[a]pyrene (B[a]P) by P4501A1
(6). In addition, quercetin has been sug-
gested to inhibitlipoxygenase andcyclooxy-
genase activities (8). Quercetin inhibits
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chemically induced tumorigenesis in the
skin, mammarygland, and colon (9).
Among the flavanones, naringenin has
received much attention. It is an effective
inhibitor ofthe P4503A4-catalyzed oxida-
tion of calcium-blocker drugs such as
nifedipine and felodipine (10). This
inhibitory effect has been shown in vivo by
the ingestion of grapefruit juice (11),
which is rich in naringin, the glycoside of
naringenin. Another flavanone, hesperetin,
and a flavone, apigenine, which are present
in grapefruit juice, had similar inhibitory
activities (10). Naringenin also inhibits the
activation of aflatoxin B1 and B[a]P
(10,12). At low doses, flavanones induced
glutathione S-transferase and glucuronida-
tion activities (13). Because oftheir activi-
ties in inhibiting carcinogen activation and
inducing phase II enzymes, flavones are
expected to inhibit tumorigenesis induced
by the above carcinogens; however, this
remains to be demonstrated.
Isoflavones and their glucosides are pre-
sent in high concentrations in soyproducts;
daidzein and genistein have received the
most attention. These compounds are
known to be inhibitors ofcarcinogenesis,
agonists and antagonists of estrogen,
inhibitors of protein tyrosine kinase,
inhibitors of angiogenesis, inducers of
apoptosis, and to have other biological
functions (14).
Tea Polyphenols and
Inhibition of
Carcinogenesis
in Animal Models
The chemistry of tea has been reviewed
previously (15,16). Although it remains to
be substantiated further, the major anti-
cancer components in tea are believed to
be the tea polyphenols, also known as cat-
echins. In green tea, (-)-epigallocatechin
gallate (EGCG), (-)-epigallocatechin
(EGC), (-)-epicatechin-3-gallate (ECG),
and (-)-epicatechin (EC) are the major
polyphenols. In the manufacture ofblack
tea, most ofthese compounds are oxidized
and polymerized to form theaflavins, which
give the reddish color of black tea, and
thearubigins, which are not well char-
acterized chemically. The structures of
some of the major tea polyphenols are
shown in Figure 1.
Tea extracts and tea polyphenols inhibit
tumorigenesis in a variety ofanimal mod-
els in different organ sites. Some recent
studies from our laboratory and others are
discussed herein.
LungTumorigenesis
Green tea infusion (e.g., 1.25 g oftea leaves
brewed in 100-ml boiling water) as the sole
source ofdrinking fluid to A/J mice signifi-
cantly decreased N-nitrosodiethylamine
(NDEA)-induced lung tumor incidence
(by 36 to 44%) and tumor multiplicity (by
44 to 60%) (17). Decaffeinated green tea
(DGT) or decaffeinated black tea (DBT)
extracts (e.g., 0.6-g dehydrated tea extract
reconstituted in 100-ml distilled water)
also inhibited lung tumorigenesis caused by
4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK) (17). The tumor multi-
plicity was reduced by 65 to 85%, and
tumor incidence was inhibited to a lesser
extent, which showed 14 to 30% inhibi-
tion in some ofthe experiments. In both
A
OH
HO II cI" OH
OH OH
(-)-Epicatechin
OH
(-)-Epigallocatechin
B
models, tea preparations were effective
when administered to mice either during
or after the carcinogen treatment period.
To gain mechanistic information, mice
were given DGT in different time periods
before or after the NNK treatment (18).
Treatment with DGT starting 2 weeks
before and continuing until 1 week after
the NNK injection was more effective in
reducing tumor multiplicity (56%) than
treatment starting 2 days before NNK
injection (31%). When tea was given to
the mice immediately after the NNK
treatment for a period of 1 week, tumor
multiplicity was also reduced (20%).
Tumor multiplicity was inhibited (54%)
even when DGT administration was
started at 5 weeks after NNK treatment.
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Figure 1. Structures of majortea polyphenols in (A)green tea and(B) black tea. R, galloyl.
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Similar inhibitory activity was also
observed by other investigators in lung
tumorigenesis induced by NDEA, B[a]P,
and NNK (17,19,20).
Esophageal Cacinogenesis
When 0.6% DGT or DBT extracts were
given to male Sprague-Dawley rats as the
drinking fluid during the N-nitrosomethyl-
benzylamine (NMBzA) treatment period,
esophageal tumor incidence and multiplic-
ity were reduced by approximately 70%
(21). When the tea preparations were
given after the NMBzA treatment period,
the esophageal papilloma incidence and
multiplicity were reduced by approxi-
mately 50%. The volume per tumor was
also reduced in rats that received DBT
after the carcinogen treatment period. In a
second experiment, the rats received 0.9%
regular green tea or DGT after the
NMBzA treatment period; the tumor mul-
tiplicity was decreased by more than 55%
at 16 weeks after the first dose ofNMBzA.
The volume per tumor was reduced by
approximately 60% in the rats receiving
0.9% regular green tea. Histological analy-
sis indicated that both the incidence and
multiplicity of esophageal carcinoma were
decreased by treatment with either regular
green tea or DGT (21).
Our results (21) confirmed the observa-
tions by Han and Xu (22), who demon-
strated the inhibitory activity ofthree brands
ofgreen tea, one brand ofoolong tea, and
one brand ofblack tea against esophageal
tumorigenesis in Wistar rats. In their study,
tea and the carcinogen NMBzAwere admin-
istered during the entire experimental
period. Our results (21) demonstrated that
tea administration was effective when given
during either the initiation or postinitiation
stage, and that DGT is also effective. Green
tea extracts have also been shown to inhibit
esophageal tumorigenesis in mice induced by
precursors ofN-nitrososarcosine (23).
GastricCarinogenesis
In the previously described NDEA-
induced carcinogenesis model with A/J
mice, forestomach tumorigenesis was also
significantly inhibited by green tea infusion
(17). In this model, hyperplasia, papillo-
mas, carcinoma in situ, and squamous cell
carcinomas in the forestomach were
observed. Tea treatment inhibited the
tumor multiplicity (up to 63% inhibition)
more effectively than tumor incidence (up
to 26% inhibition). The tumor volume
was lower in the mice in the tea treatment
group than in the control group (17).
Similar inhibitory activity by green tea
preparations has also been observed in
mouse forestomach tumors induced by
NDEA or B[a]P (19,24) and by precur-
sors ofnitrosamines (23,25). Inhibition of
gastric cancer induced by N-methyl-N-
nitro-N-nitrosoguanidine in rats by green
tea extract (26) and EGCG (27) has also
been reported. In the latter study, EGCG
(0.05% in water) administration to the rats
in the drinking fluid for 15 weeks after a
28-week treatment with the carcinogen
caused a 50% reduction in glandular
tumor incidence (27).
OtherLaboratoryStudies
More than 20 laboratories in several coun-
tries have reported the inhibitory action of
tea against tumorigenesis in animal models
on different organ sites, such as skin,
esophagus, forestomach, stomach, duode-
num and small intestine, colon, lung, liver,
pancreas, and mammary gland. Among
these, skin tumorigenesis has been studied
most extensively. Some of this work has
been reviewed previously (16,28,29). Skin
tumorigenesis caused by ultraviolet light,
chemicals, and tumor promoters was
inhibited by different tea preparations and
tea polyphenols (30,31). When mice bear-
ing chemically induced or ultraviolet light-
induced skin papillomas were given
different tea preparation or EGCG, partial
tumor regression or marked inhibition of
tumor growth was observed (32).
Tea Consumption
and Human Cancer
A 1991 International Agency for Research
on Cancer monograph (33) concluded,
"There is inadequate evidence for the car-
cinogenicity in humans and experimental
animals oftea drinking." In the review on
"Tea and Cancer" in 1993, we concluded
that no clear-cut condusion could be drawn
concerning the protective effects of tea
against human cancers (16). The conclu-
sion still held true after inclusion ofthe 17
new case-control studies (28,34-50) pub-
lished after our review. A summary of
case-control studies on the relationship
between tea consumption and human
cancers is shown in Table 1.
TeaConsumption
andEsophageal Cancer
As reviewed previously (16), early litera-
ture suggested that excessive consumption
oftea was a causative factor for esophageal
cancer. Several case-control studies, how-
ever, showed that there was no association
Table 1. Recentcase-control studies on the associa-
tion between tea consumption and human cancers.a
Number of reports
Organs Negative Positive No relationship
Bladderand - - 17
urinarytract
Breast - - 6
Colon and rectum 4 1 6
Esophagus 1 7b 6
Kidney - 1 5
Liver - - 1
Lung - 1 1
Nasopharynx - - 3
Oral and tongue 1 - 1
Pancreas 2 1 8
Prostate - - 1
Stomach 4 1 8
"Studies since 1992. bSiXstudies were with hottea.
between drinking tea at normal tempera-
ture and esophageal cancer; ingestion of
very hot tea, however, was associated with a
2- to 3-fold increase in risk for esophageal
cancer. The high temperature of hot tea,
rather than the chemicals in the tea, was
suggested to be an important etiological
factor in human esophageal cancer (33). A
recent small case-control study conducted
in northern China (38) reported that the
high temperatures ofthe meals and drinks
had a strong association with esophageal
cancer risk. After adjustment for the tem-
perature, however, tea consumption was
still a risk factor. On the other hand, a
recent report by Gao et al. (36) indicated
that, in a case-control study on 902
patients and 1552 controls in Shanghai, fre-
quent consumption ofgreen tea was associ-
ated with a lower incidence ofesophageal
cancer. After adjustment for age and other
possible confounding factors, a protective
effect ofgreen tea drinking on esophageal
cancer was observed among women: odds
ratio, 0.50; 95% confidence interval, 0.30
to 0.83; this risk decreased (p<0.01) as the
quantity of tea consumption increased.
Among men, the protective effect was not
statistically significant. Among nonsmokers
and drinkers of nonalcoholic beverages,
however, statistically significant decreases in
risk were observed among tea drinkers for
both men (69 cases and 192 controls) and
women (194 cases and 564 controls).
TeaConsumption
andStomach Cancer
Early correlative and cohort studies indi-
cated that tea consumption was either nega-
tively or positively associated with stomach
cancer (51-53). Many case-control studies
on stomach cancer and tea consumption
Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997 973YANG ET AL.
conducted in different areas, however,
indicated that there was no significant asso-
ciation between tea consumption and
cancer ofthe stomach (16,29). Some more
recent case-control studies suggested that
tea consumption reduced the risk ofstom-
ach cancer in Kyushu (Japan) (54),
Shanghai (China) (55), northwestern
Turkey (47), and central Sweden (42). For
example, in Kyushu (139 cases and 2574
controls), individuals who consumed green
tea more frequently or in larger quantities
(10 or more cups a day) tended to have a
lower risk for gastric cancer (54). In a pop-
ulation-based case-control study (669 cases
and 880 controls) in central Sweden, tea
(mostly black tea) consumption was associ-
ated with a lower incidence of gastric
cancer (42).
Different etiological factors and molec-
ular mechanisms may be involved in vary-
ing types ofcancers in different geographic
areas. Therefore, it is not surprising that a
clear-cut conclusion on the relationship
between tea consumption and human
cancer has not been found. Many con-
founding factors, such as cigarette smoking,
alcohol drinking, and the temperature of
tea, have been adjusted in many newer
studies, and these results tend to be more
informative. Another key factor that needs
to be incorporated in future studies is the
quantity and type oftea consumed.
Possible Active Tea
Components and
TheirTissue Levels
One factor to be considered in correlating
laboratory observations to epidemiological
studies is the quantities oftea used in animal
studies in comparison to those consumed by
humans. To conduct quantitative analyses,
we developed a method for the quantifica-
tion of plasma and tissue levels of tea
polyphenols (56). Plasma EGCG, EGC,
and EC exist in free and conjugated (glu-
curonide and sulfate) forms. The plasma tea
polyphenol levels in rats and mice in our
anticarcinogenesis experiments were compa-
rable to the peak levels in humans after con-
suming two or three cups oftea (29). The
peakplasma polyphenol levels were observed
at 1.5 to 2 hr after ingestion, and plasma
EGCG, EGC, and EC had half-lives of3 to
5 hr (CYangetal., unpublished results).
In a preliminary experiment, after
administration ofregular green tea in drink-
ing fluid to rats, substantial amounts (220
and 46 ng/g wet weight, respectively) and
esophagus (850 and 280 ng/g, respectively).
The EGCG was detected in the esophagus
(410 ng/g) but not in the lung. The EGCG,
EGC, and EC levels in the small intestine
and intestinal contents were rather high
(1.5-5.5 mg/g) due to the unabsorbed and
biliary excreted glucuronides ofpolyphenols
in the intestine. High EGC and EC levels
were also observed in the colon tissues (1.8
and 0.3 mg/g, respectively). Due to possible
glucuronidase and esterase activities in the
colon, most ofthe EGC and ECwere found
in the free form, and EGCG was found at
lower levels. EGCG has been usually con-
sidered the active anticarcinogenic compo-
nent in tea because it is the most abundant
polyphenol in tea. Indeed, inhibition of
lung and colon carcinogenesis by EGCG
has been reported (20,57,58). Our results
on tissue levels suggest that EGCG is con-
verted to EGC, and thus EGC rather than
EGCG may be the main active compound
involved in both models. EGC and EGCG
had similar potency (IC50 of30-50 FiM) in
inhibiting the growth ofcolon cancer cell
line HT-29 (G Yang, J Liao, F Kim,
C.Yang, unpublished results). These results
demonstrate the importance of active
components, especially when a mixture of
compounds is used.
In black tea, the level of catechins is
about 30% that of green tea, but the
inhibitory activity against tumorigenesis of
black tea was comparable to that ofgreen
tea in several animal models (17,21,31).
The effective components in black tea are
not clearly understood. Theaflavins and
thearubigins contain multiple hydroxyl
groups and possess antioxidative activities.
The antioxidative and antimutagenic
effects of theaflavins from black tea have
been reported recently (59). Other non-
polyphenolic constituents may also play a
role in the antitumorigenic activities
of tea. Tumorigenesis studies indicated
that decaffeinated tea displayed similar
inhibitory activity to regular green tea in
some experiments (17,21) but was less
effective in other experiments (31), sug-
gesting that caffeine also possesses
inhibitory activities in some animal mod-
els. Xu et al. (20) reported that oral feed-
ing ofcaffeine to A/J mice also inhibited
NNK-induced lung tumorigenesis.
Possible Mechanisms
forthe Inhibition
ofTumorigenesis
The most noteworthy properties of tea
polyphenols and other flavonoids are their
antioxidative activities (16). Reactive oxy-
gen species may play important roles in
carcinogenesis through damaging DNA,
altering gene expression, or affecting cell
growth and differentiation (60,61). The
anticarcinogenic activities oftea polyphenols
are believed to be closely related to their
antioxidative properties. The findings that
green tea preparations inhibited 12-0-
tetradecanoylphorbol-13-acetate-induced
hydrogen peroxide formation in mouse epi-
dermis (62) and NNK-induced 8-hydroxy-
deoxyguanosine formation in mouse lung
(20) are consistent with this concept.
Inhibition of tumor promotion-related
enzymes such as ornithine decarboxylase
(62,63), protein kinase C (64), lipoxy-
genase, and cyclooxygenase (19) by tea
preparations has also been reported.
Although inhibition of carcinogen activa-
tion by tea or green tea polyphenol frac-
tions could be demonstrated in vitro and,
in certain cases, in vivo (65,66), this
mechanism was not demonstrated for
NNK bioactivation in vivo (18,20). Oral
administration of tea preparations to ani-
mals has been reported to moderately
enhance the activities of glutathione per-
oxidase, catalase, glutathione S-transferase,
NADPH-quinone oxidoreductase, uridine
diphosphate-glucuronosyltransferase, and
methoxyresorufin O-dealkylase (67-69).
The effects of a mild induction of these
enzymes on carcinogenesis are not clear.
Mechanisms relating to the quenching of
activated carcinogens, antiviral activity, and
enhancing immune functions have also been
suggested, but their relevance to carcinogen-
esis remains to be determined (16).
Inhibition ofnitrosation by tea preparations
has been demonstrated in vitro and in
humans (70,71); this may be an important
factor in preventing certain cancers, e.g.,
gastric cancer, ifthe endogenously formed
N-nitroso compounds are causative factors.
Our recent results (72) suggest that the
antiproliferative effect oftea is important for
the anticarcinogenic activity. One may
speculate that tea polyphenols inhibit
growth-related signal transduction pathways.
Conclusion
Although the anticarcinogenic activity oftea
and polyphenols has been demonstrated in
many animal studies, such activity has not
been clearly demonstrated in humans. More
epidemiological investigations, especially
prospective studies, concerning the effect of
polyphenol consumption on human cancer
risk are needed. Because the causative factors
may be different for different cancers and
for the same cancer in different populations,
the effects may vary in different situations.
Therefore, in future epidemiological studies,
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it is important to consider the etiological
factors ofthe specific cancers and to collect
specific information on the quantitative
aspects ofpolyphenol consumption. Urinary
excretion of metabolites of polyphenols
may be used as an exposure biomarker.
Definitive information on the protective
effects of polyphenol consumption on
cancer will come from intervention studies.
Based on the suggestive epidemiological
data from Shizuoka, Kyushu (54),
Shanghai (55), northwestern Turkey (47),
and central Sweden (42), future interven-
tion studies on gastric and esophageal can-
cers with tea preparations among high-risk
populations should be very worthwhile.
Intervention trials with other polyphenols
should also be encouraged.
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